OpGen Inc (NAS:OPGN)
$ 3.3112 0 (0%) Market Cap: 4.18 Mil Enterprise Value: 16.43 Mil PE Ratio: 0 PB Ratio: 1.24 GF Score: 36/100

Q2 2022 OpGen Inc Earnings Call Transcript

Aug 11, 2022 / 08:30PM GMT
Release Date Price: $126 (+5.00%)
Operator

Ladies and gentlemen, welcome to the OpGen Second Quarter 2022 Earnings Call and Business Update. Today, OpGen management will provide an update on the company's current business and outlook for the future. Following OpGen's prepared remarks, there will be a live Q&A session. As a reminder, this conference call is being recorded today, August 11, 2022. (Operator Instructions)

At this time, we will turn the call over to Alyssa Factor, OpGen's IR representative to provide the opening statement. Please go ahead.

Alyssa Factor;Edison Group;IR Representative

Good afternoon, everyone, and thank you, operator, for the introduction. Before we begin, I'd like to note that any comments made by management during this conference call may contain forward-looking statements regarding the operations and future results of OpGen, including its subsidiaries, Curetis and Ares Genetics.

I encourage you to review OpGen's filings with the Securities and Exchange Commission, including, without limitation, the company's most recent

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot